Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. LifeMD, Inc.
  6. News
  7. Summary
    LFMD   US53216B1044

LIFEMD, INC.

(LFMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LifeMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

11/10/2021 | 05:02pm EST

LifeMD, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported revenue was USD 24.95 million compared to USD 11.01 million a year ago. Net loss was USD 14.35 million compared to USD 20.62 million a year ago. Basic loss per share from continuing operations was USD 0.54 compared to USD 1.65 a year ago. Diluted loss per share from continuing operations was USD 0.54 compared to USD 1.65 a year ago. For the nine months, revenue was USD 65.46 million compared to USD 24.4 million a year ago. Net loss was USD 42.79 million compared to USD 26.4 million a year ago. Basic loss per share from continuing operations was USD 1.66 compared to USD 2.47 a year ago. Diluted loss per share from continuing operations was USD 1.66 compared to USD 2.47 a year ago.


ę S&P Capital IQ 2021
All news about LIFEMD, INC.
01/19LIFEMD, INC. : Regulation FD Disclosure (form 8-K)
AQ
01/19LIFEMD : Provides Initial FY2022 Guidance and Announces Preliminary FY2021 Revenues - Form..
PU
01/19LIFEMD, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
01/19LifeMD Provides Initial FY2022 Guidance and Announces Preliminary FY2021 Revenues
AQ
01/19LifeMD, Inc. Provides Earnings Guidance for the Year 2022; Provides Earnings Guidance f..
CI
01/19LifeMD, Inc. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year of ..
CI
01/18LifeMD to Participate in the Upcoming Virtual BTIG Conference
GL
01/12LIFEMD : Expands Patient Offerings by Acquiring Leading Allergy Telehealth Platform - Form..
PU
01/12LIFEMD, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec..
AQ
01/12LifeMD Buying Allergy Telehealth Platform Cleared; Shares Rise Pre-Bell
MT
More news
Analyst Recommendations on LIFEMD, INC.
More recommendations
Financials (USD)
Sales 2021 92,9 M - -
Net income 2021 -57,9 M - -
Net cash 2021 35,7 M - -
P/E ratio 2021 -1,36x
Yield 2021 -
Capitalization 89,3 M 89,3 M -
EV / Sales 2021 0,58x
EV / Sales 2022 0,47x
Nbr of Employees 56
Free-Float 72,0%
Chart LIFEMD, INC.
Duration : Period :
LifeMD, Inc. Technical Analysis Chart | LFMD | US53216B1044 | MarketScreener
Technical analysis trends LIFEMD, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 2,92 $
Average target price 16,00 $
Spread / Average Target 448%
EPS Revisions
Managers and Directors
Justin Schreiber Chairman & Chief Executive Officer
Alexander Mironov President
Marc Benathen Chief Financial Officer
Joseph V. DiTrolio Chief Medical Officer-US
Stefan Galluppi Chief Innovation & Marketing Officer
Sector and Competitors
1st jan.Capi. (M$)
LIFEMD, INC.-24.55%89
AMAZON.COM, INC.-14.44%1 446 821
JD.COM, INC.4.84%113 418
ETSY, INC.-32.01%18 871
WAYFAIR INC.-26.45%14 607
ALLEGRO.EU SA3.55%9 969